4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-21-014860
Director acquired 24,720 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Mulroy Michael H. · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-06-18 | Exercise or conversion : show line 1 in the form | +24,720 | $2.20 | $54,384 | 251,555 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-06-18 | Exercise or conversion : show line 2 in the form Stock Option (right to buy) | −24,720 | 0 | D |
Loading xslF345X03/ownership.xml…